EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Role of cholesterol in modulating brain hyperexcitability

James W Wheless iD, Jong M Rho iD

Epilepsia · 2025-01 · 66 (1) · 33-46

DOI: 10.1111/epi.18174 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Epilepsia, online erschienen am 02.11.2024. Verfasst von James W Wheless und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Neurology, University of Tennessee Health Science Center, Memphis, Tennessee, USA. Hauptthemen laut MEDLINE: Cholesterol, Brain, Epilepsy. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Takeda Pharmaceuticals U.S.A..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cholesterol is a critical molecule in the central nervous system, and imbalances in the synthesis and metabolism of brain cholesterol can result in a range of pathologies, including those related to hyperexcitability. The impact of cholesterol on disorders of epilepsy and developmental and epileptic encephalopathies is an area of growing interest. Cholesterol cannot cross the blood–brain barrier, and thus the brain synthesizes and metabolizes its own pool of cholesterol. The primary metabolic enzyme for brain cholesterol is cholesterol 24‐hydroxylase (CH24H), which metabolizes cholesterol into 24 S ‐hydroxycholesterol (24HC). Dysregulation of CH24H and 24HC can affect neuronal excitability through a range of mechanisms. 24HC is a positive allosteric modulator of N‐methyl‐D‐aspartate (NMDA) receptors and can increase glutamate release via tumor necrosis factor‐α‐dependent pathways. Increasing cholesterol metabolism can lead to dysfunction of excitatory amino acid transporter 2 and impair glutamate reuptake. Finally, overstimulation of NMDA receptors can further activate metabolism of cholesterol, leading to a vicious cycle of overactivation. All of these mechanisms increase extracellular glutamate and can lead to hyperexcitability. For these reasons, the cholesterol pathway represents a new potential mechanistic target for antiseizure medications. CH24H inhibition has been shown to decrease seizure behavior and improve survival in multiple animal models of epilepsy and could be a promising new mechanism of action for the treatment of neuronal hyperexcitability and developmental and epileptic encephalopathies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholesterolBrainEpilepsyHumansAnimalsReceptors, N-Methyl-D-AspartateCholesterol 24-Hydroxylase

Stichwörter der Autor:innen

24S‐hydroxycholesterolcholesterol 24‐hydroxylasedevelopmental and epileptic encephalopathiesepilepsy

Substanzen

CholesterolReceptors, N-Methyl-D-AspartateCholesterol 24-Hydroxylase

Autor:innen und Institutionen

  • Division of Pediatric Neurology, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
  • Department of Neurosciences, Pediatrics and Pharmacology, University of California San Diego School of Medicine, San Diego, California, USA.
  • Rady Children's Hospital-San Diego, San Diego, California, USA.

ORCID-Profile: James W Wheless, Jong M Rho

Förderung

  • Takeda Pharmaceuticals U.S.A.

Zitieren

APA

Wheless, J. W., & Rho, J. M. (2025). Role of cholesterol in modulating brain hyperexcitability. Epilepsia, 66(1), 33-46. https://doi.org/10.1111/epi.18174

Vancouver

Wheless JW, Rho JM. Role of cholesterol in modulating brain hyperexcitability. Epilepsia. 2025;66(1):33-46. doi:10.1111/epi.18174

BibTeX
@article{Wheless2025,
  author = {Wheless, James W and Rho, Jong M},
  title = {Role of cholesterol in modulating brain hyperexcitability},
  journal = {Epilepsia},
  year = {2025},
  volume = {66},
  number = {1},
  pages = {33--46},
  doi = {10.1111/epi.18174}
}
Kostenlos starten →